Neurofibromatosis 2 gene has novel alternative splicings which controls intracellular protein binding

International Journal of Oncology

Volumn 10, Issue 5, 1997, Pages 1025-1029

  Nishi, Toru ^a   Takeshima, Hideo ^a   Hamada, Kazuya ^a   Yoshizato, Kimio ^a   Koga, Hisashi ^a   Sato, Kyoichi ^a   Yamamoto, Keizo ^a   Kitamura, Isao ^a   Kochi, Masato ^a   Kuratsu, Jun Ichi ^a   Saya, Hideyuki ^a   Ushio, Yukitaka ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

alternative splicing; binding protein; exon skipping; glioblastoma; NF2 gene

Indexed keywords

ALTERNATIVE RNA SPLICING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE; GLIOMA; HUMAN; HUMAN TISSUE; NEURILEMOMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 12644306865     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.10.5.1025     Document Type: Article

References (5)

1. Eldridge R: Central neurofibromatosis with bilateral acoustic neuroma. Adv Neurol 29: 57-65, 1981.
2. Martuza RL and Eldridge R: Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). N Engl J Med 31: 684-688, 1988.
3. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, Hasse VH, Ambrose CM, Munroe D, Bove C, Haines JL, Martuza RL, MacDonald ME, Seizinger BR, Short MP, Buckler AJ and Gusella JF: A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72: 791-800, 1993.
4. Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang XK, Demczuk S, Desmaze C, Plougastel B, Pulst SM, Lenoir B, Bijlsma E, Fashold R, Dumanski J, Jong PD, Parry D, Eldrige R, Aurias A, Delattre O and Thomas G: Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 363: 515-521, 1993.
5. Fazioli F, Wong WT, Ullrich SJ, Sakaguchi K, Appella E and Fiore PPD: The ezrin-like family of tyrosine kinase substrates: receptor-specific pattern of tyrosine phosphorylation and relationship to malignant transformation. Oncogene 8: 1335-1345, 1993.